HIGHLIGHTS
- who: Yegnasew Takele and colleagues from the Research and Treatment Centre, University of Gondar, Ethiopia, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom have published the research work: Following successful anti-leishmanial treatment, neutrophil counts, CD10 expression and phagocytic capacity remain reduced in visceral leishmaniasis patients co-infected with HIV, in the Journal: (JOURNAL) of March/13,/2022
- what: The authors show that over time in VL/HIV patients the neutrophil counts remain significantly lower as compared to VL patients and healthy controls and they also display an impaired capacity to phagocytose.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.